title: Retinoids inhibit protein kinase C-dependent transduction of 1,2-diglyceride signals in human colonic tumor cells.
abstract: 1,2-Diglycerides with long-chain fatty acid residues related to nutritional fat (LCDGs) specifically affect growth and urokinase secretion in human colonic tumor cells, but not in normal mucosa. This allows them to advance and enhance carcinogenesis in the colon and rectum. SW480 colon carcinoma cells are LCDG sensitive in the same way as primary colonic tumor cells and have therefore been used as a model system to study the mechanism of LCDG action and to search for inhibitors of tumor development in the colon. Using this model system, we have shown that the effects of LCDGs are transmitted by protein kinase C and abolished by downregulation of the enzyme. Retinol, retinoic acid, and beta-carotene in nanomolar concentrations inhibit LCDG-induced growth and urokinase secretion and block stimulation of protein kinase C. Although retinol and retinoic acid at higher concentrations also display stimulatory activity, beta-carotene does not. At 100 nM, a concentration that can easily be reached in the plasma of humans, beta-carotene reduces LCDG-induced urokinase secretion about 50%. Inasmuch as beta-carotene does not have side effects due to intrinsic activities and storage effects, beta-carotene and foods rich in carotenes could be useful in the prevention of colorectal cancer.
authors.affiliation: Institute for Tumor Biology-Cancer Research, University of Vienna, Austria.
authors.forename: P
authors.initials: P
authors.lastname: Kahl-Rainer
authors.forename: B
authors.initials: B
authors.lastname: Marian
mesh_terms: D002338:Carotenoids / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D004075:Diglycerides / Q000037:antagonists & inhibitors*; D006801:Humans; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*; D012176:Retinoids / Q000494:pharmacology*; D015398:Signal Transduction / Q000187:drug effects*; D014407:Tumor Cells, Cultured; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism; D019207:beta Carotene
chemical_list: D004075:Diglycerides; D012176:Retinoids; D019207:beta Carotene; D002338:Carotenoids; D011493:Protein Kinase C; D014568:Urokinase-Type Plasminogen Activator